ramarketing has received a strategic investment from NorthEdge
Founded in 2009, ramarketing delivers services to over 60 clients across Europe, North America and Asia. ramarketing operates in the pharmaceutical and life sciences sector providing design, digital and content services. The company specializes in helping companies in the pharmaceutical supply chain raise profile, manage reputation and increase visibility while also generating and converting leads. ramarketing provides an outsourced solution to some of the biggest names in the pharmaceutical and biotech industries across the globe.
With NorthEdge’s support, ramarketing will continue to expand and support its international client base, building on its reputation as a leading provider of marketing services for companies in the life sciences sector. Its growth plan is underpinned by strong market fundamentals, with outsourced marketing spend in the life sciences market forecast to grow by approximately 12% CAGR through to 2024.
Raman Sehgal, Founder and Global President of ramarketing, commented, “Lincoln’s deep knowledge of the pharmaceutical and biotech outsourcing sector, alongside their strategic advice at every step across this journey, has undoubtedly resulted in the best possible outcome for the ramarketing shareholders and management team, going beyond our expectations.”
James West, Director in Lincoln’s Healthcare Group, commented, “We are excited to have advised ramarketing on this strategic investment from NorthEdge Capital. This will allow ramarketing to capitalize on its leading position in this high-growth and highly specialist market. It was a pleasure to work with Raman and the ramarketing team.”
NorthEdge is a lower mid-market private equity firm headquartered in Northern England. The company is owned and built by its senior team and supported by a global blue-chip investor base. NorthEdge has £900 million assets under management (AUM) across four regionally focused funds.
The team at Lincoln has been a pleasure to work with, highly collaborative and 100% dedicated to delivering the best service. We viewed them as a trusted partner throughout the transaction. Great team, great people. I highly recommend them.
Meet our Senior Team
View More Transactions in Healthcare
Lincoln International advised Pfingsten Partners on the sale of Full Spectrum Group to CBRE Group
Lincoln International advised Rarebreed, a portfolio company of Trilantic Capital Partners and Halle Capital Management, on receiving significant investment from Revelstoke Capital Partners
Lincoln International advised Corus a portfolio company of Careventures and Quadrum Capital on the refinancing and acquisition of Nordentic
Lincoln International advised EverVet Partners, a portfolio company of Tailwind Capital, on receiving a significant investment from Freeman Spogli & Co.
Lincoln International has advised All About Children on its sale to Partou, a portfolio company of Waterland Private Equity
Lincoln International advised SEKISUI CHEMICAL on the sale of SEKISUI XENOTECH to BioIVT, a portfolio company of Linden Capital Partners
Any information or testimonials contained in this post may not be representative of the experience of other clients and is no guarantee of future performance or success.